June 2, 2016 — Physicians have long used magnetic resonance imaging (MRI) to detect cancer, but a new study describes the potential use of restriction spectrum imaging (RSI) as an imaging biomarker for prostate cancer.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now